These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9409651)

  • 1. Antigen-presenting cells (APC) of mice with chronic graft-versus-host disease (GVHD) cause excessive activation-induced death of T helper cells.
    Haridas V; Kamat RS
    Clin Exp Immunol; 1997 Dec; 110(3):454-63. PubMed ID: 9409651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.
    Rozendaal L; Pals ST; Gleichmann E; Melief CJ
    Clin Exp Immunol; 1990 Dec; 82(3):527-32. PubMed ID: 2148286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
    Pals ST; Radaszkiewicz T; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases.
    Gleichmann E; Gleichmann H
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):115s-120s. PubMed ID: 3159804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex restriction of T-cell suppression of immune response to mycobacteria.
    Shroff KE; Sainis KB; Sengupta SR; Kamat RS
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):49-57. PubMed ID: 1827647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL; Forman J
    J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of murine acute graft-versus-host disease by staphylococcal enterotoxin B treatment.
    Takenaka K; Fujiyama Y; Andoh A; Sasaki T; Amakata Y; Matsubara H; Hodohara K; Bamba T
    Clin Exp Immunol; 2001 Jan; 123(1):155-61. PubMed ID: 11168013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.
    Rolink AG; Gleichmann E
    J Exp Med; 1983 Aug; 158(2):546-58. PubMed ID: 6224882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
    Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
    Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease.
    Tschetter JR; Mozes E; Shearer GM
    J Immunol; 2000 Nov; 165(10):5987-94. PubMed ID: 11067962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.
    van Rappard-Van der Veen FM; Kiesel U; Poels L; Schuler W; Melief CJ; Landegent J; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1814-20. PubMed ID: 6321591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of three PPD-reactive helper T cell clones with distinct functions in B cell activation.
    Sano Y; Yamada G; Dobashi K; Mizuochi T; Hamaoka T; Takatsu K
    J Immunol; 1984 Aug; 133(2):629-35. PubMed ID: 6234353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective reversal of H-2-linked genetic unresponsiveness to lysozymes. II. Alteration in the T helper/T suppressor balance, owing to gene(s) linked to Ir-2, leads to responsiveness in BALB.B.
    Sadegh-Nasseri S; Dessi V; Sercarz EE
    Eur J Immunol; 1986 May; 16(5):486-92. PubMed ID: 2938974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.